Correlation Between Analyst IMS and Clal Biotechnology

Can any of the company-specific risk be diversified away by investing in both Analyst IMS and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Analyst IMS and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Analyst IMS Investment and Clal Biotechnology Industries, you can compare the effects of market volatilities on Analyst IMS and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Analyst IMS with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Analyst IMS and Clal Biotechnology.

Diversification Opportunities for Analyst IMS and Clal Biotechnology

-0.32

Correlation Coefficient

Analyst IMS  Clal Biotechnology

Very good diversification

The 3 months correlation between Analyst and Clal is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Analyst IMS Investment and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and Analyst IMS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Analyst IMS Investment are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of Analyst IMS i.e., Analyst IMS and Clal Biotechnology go up and down completely randomly.

Pair Corralation between Analyst IMS and Clal Biotechnology

Assuming the 90 days trading horizon Analyst IMS Investment is expected to generate 0.94 times more return on investment than Clal Biotechnology. However, Analyst IMS Investment is 1.06 times less risky than Clal Biotechnology. It trades about 0.47 of its potential returns per unit of risk. Clal Biotechnology Industries is currently generating about 0.0 per unit of risk. If you would invest  579,900  in Analyst IMS Investment on December 27, 2024 and sell it today you would earn a total of  329,900  from holding Analyst IMS Investment or generate 56.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Analyst IMS Investment  vs.  Clal Biotechnology Industries

Analyst IMS Investment

Risk-Adjusted Performance

Very Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Analyst IMS Investment are ranked lower than 36 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Analyst IMS sustained solid returns over the last few months and may actually be approaching a breakup point.

Clal Biotechnology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, Clal Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Analyst IMS and Clal Biotechnology

The main advantage of trading using opposite Analyst IMS and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Analyst IMS position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.

The idea behind Analyst IMS Investment and Clal Biotechnology Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..